Screening for Abdominal Aortic Aneurysm in 65 Year Old Males in Oslo (AAAscreening)

March 29, 2016 updated by: Jorgen J Jorgensen, Oslo University Hospital

Screening for Abdominal Aortic Aneurysm

Male subjects, 65 years of age, living in Oslo, Norway will be invited to be screened for abdominal aortic aneurysm.

Study Overview

Status

Enrolling by invitation

Detailed Description

The invited population will be offered ultrasound investigation of their abdominal aorta. Further information regarding risk factors will be noted and measurement of ankle-brachial index will be measured/calculated. A further step in the future will be to sample blood with focus on different cytokines and genmediators.

Study Type

Observational

Enrollment (Actual)

7500

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 65 years (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Sampling Method

Probability Sample

Study Population

65 year old males in Oslo

Description

Inclusion Criteria:

  • Males aged 65 years

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Abdominal Aortic Aneurysm (AAA)
Time Frame: Yearly the number of patients with AAA among the screened population will be assessed during the inclusion period of 18 years..
AAA definition: diameter equal or more than 30 mm. The number of identified patients with AAA will be yearlig assessed.
Yearly the number of patients with AAA among the screened population will be assessed during the inclusion period of 18 years..

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peripheral Arterial Disease (PAD)
Time Frame: Yearly the number of patients with PAD among the screened poplulation will be assessed during the inclusion period of 18 years.
Investigate the prevalence of PAD among patients with AAA defined as having Ankle-Arm Index (AAI) less than 0.9. The number of these patients will be assessed yearly.
Yearly the number of patients with PAD among the screened poplulation will be assessed during the inclusion period of 18 years.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2011

Primary Completion (Anticipated)

December 1, 2029

Study Completion (Anticipated)

December 1, 2029

Study Registration Dates

First Submitted

November 11, 2010

First Submitted That Met QC Criteria

November 24, 2010

First Posted (Estimate)

November 25, 2010

Study Record Updates

Last Update Posted (Estimate)

March 30, 2016

Last Update Submitted That Met QC Criteria

March 29, 2016

Last Verified

March 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All data are entered into the Electronic Patient Journal of Oslo University Hospital (DIPS)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abdominal Aortic Aneurysm

3
Subscribe